Imeik Technology Development Co Ltd. Stock Analysis 300896.SZ

Imeik Technology Development Co., Ltd. engages in the research, development, production and sale of biomedical materials and biopharmaceuticals. The company is headquartered in Beijing, Beijing and currently employs 1,458 full-time employees. The company went IPO on 2020-09-28. The Company’s main products include a series of dermal fillers based on sodium hyaluronate, dermal fillers based on polylactic acid, facial implants based on polydioxanone, and other products. The Company’s products are used in a variety of clinical applications, including aesthetic medicine, surgical repair, and metabolic disease treatment. The firm conducts its business in the domestic and overseas markets.